APA (7th ed.) Citation

R, L., E, M., A, L., N, G., I, C., A, A., . . . D, V. (2023). Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 29(21), 4419. https://doi.org/10.1158/1078-0432.CCR-23-0898

Chicago Style (17th ed.) Citation

R, Leman, et al. "Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 29, no. 21 (2023): 4419. https://doi.org/10.1158/1078-0432.CCR-23-0898.

MLA (9th ed.) Citation

R, Leman, et al. "Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 29, no. 21, 2023, p. 4419, https://doi.org/10.1158/1078-0432.CCR-23-0898.